The use of PERCOCET in clients with acute or intense bronchial asthma in an unmonitored environment or while in the absence of resuscitative devices is contraindicated.Exclusivity is the only real promoting rights granted from the FDA to the company upon the approval of a drug and will operate at the same time that has a patent. Exclusivity periods… Read More